1. Phase I/II study of dasatinib in combination with decitabine in patients with accelerated or blast phase chronic myeloid leukemia
    Yasmin Abaza et al, 2020, American Journal of Hematology CrossRef
  2. Deletion of MBD2 inhibits proliferation of chronic myeloid leukaemia blast phase cells
    Ling Cheng et al, 2018, Cancer Biology & Therapy CrossRef
  3. HNRNPH1 Is a Novel Regulator Of Cellular Proliferation and Disease Progression in Chronic Myeloid Leukemia
    Menghan Liu et al, 2021, Frontiers in Oncology CrossRef
  4. Decitabine Downregulates TIGAR to Induce Apoptosis and Autophagy in Myeloid Leukemia Cells
    Lanzhu Li et al, 2021, Oxidative Medicine and Cellular Longevity CrossRef
  5. Azacytidine in combination with tyrosine kinase inhibitors induced durable responses in patients with advanced phase chronic myelogenous leukemia
    Mathilde Ruggiu et al, 2018, Leukemia & Lymphoma CrossRef